Rishi Sood, MD
Vascular & Interventional Radiology · Washington, DCNPI 1881012821
Payments from drug & device makers
What this record shows
9 manufacturers reported payments, led by Medtronic at 55.8% of the total. Reporting peaked in 2019 at $379 and has fallen 82.3% since, to $67 in 2025. That places this record below the midpoint for vascular & interventional radiology clinicians in DC, where the typical reported total is $1,444.
Across 10 payments — averaging $52.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$294
- Boston Scientific$84
- Lilly USA, LLC$33
- Organogenesis Inc.$27
- Angiodynamics, Inc.$21
- Globus Medical$20
- plus $48 from 3 others
What the payments were for
- Food & beverage$23344%
- Education$29456%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 1 | $294 |
| Boston Scientific | 1 | $84 |
| Lilly USA, LLC | 2 | $33 |
| Organogenesis Inc. | 1 | $27 |
| Angiodynamics, Inc. | 1 | $21 |
| Globus Medical | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
| Boehringer Ingelheim | 1 | $16 |
| Ardelyx, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MVP$294
How this compares
$527 in reported general payments places this provider in the 25th percentile of 26 vascular & interventional radiology providers in District of Columbia.
See all vascular & interventional radiology providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 26 | $14,627 |
| ClopidogrelClopidogrel Bisulfate | 30 | $379 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Washington
- Saher SabriWashington$136K
- Emil CohenWashington$115K
- Theresa CaridiWashington$115K
- Shawn SarinWashington$35K
- Keith HortonWashington$35K
- Anthony VenbruxWashington$12K
- Faezeh RazjouyanWashington$12K
- Daniel ScherWashington$7K
- Sarah KanthariaWashington$7K
- Vishal KadakiaWashington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.